FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)